Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04777786 · ClinicalTrials.gov registry record · NA
Early Rehabilitation for Breast Cancer - A Randomized Control Trial
A NA study, sponsored by University of South Carolina.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04777786 is a NA study that was terminated before completion, run by University of South Carolina. The registered enrollment target is 3 participants.
The verdict
NCT04777786, a NA study, was terminated before completion, sponsored by University of South Carolina.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Upper extremity strength, range of motion, activity limitations, fatigue and pain are well-documented concerns for women receiving treatment for breast cancer. Research has shown that cancer-related treatment side effects are amenable to rehabilitation interventions when identified early during treatment for breast cancer. Despite this, early rehabilitation has been reported in only 1-2% of individuals diagnosed with cancer. The Prospective Surveillance Model (PSM), a comprehensive model of survivorship care supported by the American Cancer Society and the National Cancer Institute, recommends a baseline assessment (near the time of diagnosis) and ongoing surveillance and intervention of impairments that minimize the impact of cancer treatments. A significant gap in knowledge currently exists with regards to the effectiveness of employing the PSM. The purpose of this study is to examine the impact of implementing the PSM on impairments and functional limitations in women diagnosed with breast cancer during the first six months of treatment. A randomized controlled trial will be applied to examine a total of 28 women diagnosed with stage I-III breast cancer who will receive a mastectomy at Prisma Health in Columbia, S.C. Women will be randomized to one of two groups: PSM or usual care.
Interventions
- OTHER Physical Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2023-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04777786
The ClinicalTrials.gov registry entry for NCT04777786 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Physical Therapy is the first listed.
NCT04777786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04777786 about?
NCT04777786 is a clinical study titled "Early Rehabilitation for Breast Cancer - A Randomized Control Trial". Upper extremity strength, range of motion, activity limitations, fatigue and pain are well-documented concerns for women receiving treatment for breast cancer. Research has shown that cancer-related treatment side effects are amenable to rehabilitation interventions when identified early during trea...
What is the current status of trial NCT04777786?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2021-04-01. Estimated completion is 2023-03-31.
What interventions are being tested in trial NCT04777786?
The interventions under investigation include: Physical Therapy (OTHER).
Who is sponsoring clinical trial NCT04777786?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.